-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a randomized, multi-site clinical trial evaluated a single diabetic ketoacidosis (DKA) and whether the onset of a new diagnosis of type 1 diabetes in children's cognitive decline related to, and in consideration of glycemic control and other relevant factors After the change, whether the same is true for previously diagnosed children, the results of the study have been published in Diabetes Care
Diabetes diagnosis in children with type 1 diabetes
The researchers prospectively recruited 758 children with DKA between the ages of 6-18 and evaluated the intravenous infusion regimen for DKA treatment
As a result, in all patients, moderate/severe DKA was associated with lower intelligence quotient (IQ) (β = -0.
Hypoglycemia
In summary, a single episode of DKA is associated with a slight memory decline shortly after the diagnosis of type 1 diabetes
Original source:
Simona Ghetti, et al.
Cognitive Function Following Diabetic Ketoacidosis in Children With New-Onset or Previously Diagnosed Type 1 Diabetes
in this message